Regarding CD8+ T cell response, the percentage of CD8+ T cells responding to peptide pool stimulation was higher in COVID-19 patients with a moderate disease compared to either HD or recovered individuals who experienced a moderate infection. The gene discussed is CD8A; the disease is COVID-19.